Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma

Head and Neck

Volumn 35, Issue 5, 2013, Pages 720-728

  Cao, Pengyu ^a   Zhou, Liang ^a   Zhang, Jin ^b   Zheng, Fengyun ^b   Wang, Huijun ^b   Ma, Duan ^b   Tian, Jie ^a  

^a EYE AND ENT HOSPITAL OF FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

head and neck squamous cell carcinoma; laryngeal squamous cell carcinoma; laser capture microdissection; microRNA; target gene

Indexed keywords

MICRORNA; MICRORNA 125B; MICRORNA 145; MICRORNA 205; MICRORNA 21; MICRORNA 708; MICRORNA 93; UNCLASSIFIED DRUG; RNA;

ADULT; AGED; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; LARYNX SQUAMOUS CELL CARCINOMA; LASER CAPTURE MICRODISSECTION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; DISEASE COURSE; GENETICS; HEAD AND NECK TUMOR; LARYNX TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; LASER CAPTURE MICRODISSECTION; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, NEOPLASM; UP-REGULATION;

EID: 84876021970     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23011     Document Type: Article

References (52)

1. Zamore PD, Haley B,. Ribo-gnome: the big world of small RNAs. Science 2005; 309: 1519-1524.
2. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
3. Ambros V,. The functions of animal microRNAs. Nature 2004; 431: 350-355.
4. Esquela-Kerscher A, Slack FJ,. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
5. Hebert C, Norris K, Scheper MA, Nikitakis N, Sauk JJ,. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer 2007; 6:Art. 5.
6. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J,. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 2008; 68: 2094-2105.
7. Tran N, McLean T, Zhang X, et al. MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 2007; 358: 12-17.
8. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI,. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008; 14: 2588-2592.
9. Chu EA, Kim YJ,. Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am 2008; 41: 673-695, v.
10. Almadori G, Bussu F, Paludettii G,. Predictive factors of neck metastases in laryngeal squamous cell carcinoma. Towards an integrated clinico-molecular classification. Acta Otorhinolaryngol Ital 2006; 26: 326-334.
11. Huang Q, Yu GP, McCormick SA, et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 2002; 34: 224-233.
12. Zhang J, Du YY, Lin YF, et al. The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun 2008; 377: 136-140.
13. Kuhn DE, Nuovo GJ, Terry AV Jr, et al. Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. J Biol Chem 2010; 285: 1529-1543.
14. Mattes J, Collison A, Plank M, Phipps S, Foster PS,. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci U S A 2009; 106: 18704-18709.
15. Schmittgen TD, Livak KJ,. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-1108.
16. Belbin TJ, Singh B, Smith RV, et al. Molecular profiling of tumor progression in head and neck cancer. Arch Otolaryngol Head Neck Surg 2005; 131: 10-18.
17. Choi P, Chen C,. Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma. Cancer 2005; 104: 1113-1128.
18. Makitie AA, Monni O,. Molecular profiling of laryngeal cancer. Expert Rev Anticancer Ther 2009; 9: 1251-1260.
19. Chang SS, Smith I, Glazer C, Hennessey P, Califano JA,. EIF2C is overexpressed and amplified in head and neck squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2010; 72: 337-343.
20. Liu A,. Laser capture microdissection in the tissue biorepository. J Biomol Tech 2010; 21: 120-125.
21. Chang SS, Jiang WW, Smith I, et al. MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 2008; 123: 2791-2797.
22. Hui ABY, Lenarduzzi M, Krushel T, et al. Comprehensive microRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 2010; 16: 1129-1139.
23. Ramdas L, Giri U, Ashorn CL, et al. miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue. Head Neck 2009; 31: 642-654.
24. Cai KM, Bao XL, Kong XH, et al. Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met. Int J Mol Med 2010; 25: 565-571.
25. Liu M, Wu H, Liu T, et al. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res 2009; 19: 828-837.
26. Long XB, Sun GB, Hu S, et al. Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer. Oncol Rep 2009; 22: 1189-1195.
27. Ren J, Zhu D, Liu M, Sun Y, Tian L,. Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of laryngeal squamous cell carcinoma. Eur J Cancer 2010; 46: 3409-3416.
28. Wu H, Liu T, Wang R, et al. MicroRNA-16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp-2. IUBMB Life 2011; 63: 101-108.
29. Selcuklu SD, Donoghue MT, Spillane C,. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 2009; 37: 918-925.
30. Noren HN, Abdelmohsen K, Gorospe M, Ejiogu N, Zonderman AB, Evans MK,. microRNA expression patterns reveal differential expression of target genes with age. PLoS One 2010; 5: e10724.
31. Fletcher AM, Heaford AC, Trask DK,. Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir-205. Transl Oncol 2008; 1: 202-208.
32. Kimura S, Naganuma S, Susuki D, et al. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep 2010; 23: 1625-1633.
33. Greene SB, Herschkowitz JI, Rosen JM,. The ups and downs of miR-205: identifying the roles of miR-205 in mammary gland development and breast cancer. RNA Biol 2010; 7: 300-304.
34. Childs G, Fazzari M, Kung G, et al. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 2009; 174: 736-745.
35. Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601.
36. Leng S, Bernauer AM, Zhai R, et al. Discovery of common SNPs in the miR-205/200 family-regulated epithelial to mesenchymal transition pathway and their association with risk for non-small cell lung cancer. Int J Mol Epidemiol Genet 2011; 2: 145-155.
37. Zidar N, Boštjančič E, Gale N, et al. Down-regulation of microRNAs of the miR-200 family and miR-205, and an altered expression of classic and desmosomal cadherins in spindle cell carcinoma of the head and neck-hallmark of epithelial-mesenchymal transition. Hum Pathol 2011; 42: 482-488.
38. Min/+) models of colon cancer. PLoS One 2011; 6: e18501.
39. Schotte D, Chau JC, Sylvester G, et al. Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia 2009; 23: 313-322.
40. Song T, Xia W, Shao N, et al. Differential miRNA expression profiles in bladder urothelial carcinomas. Asian Pac J Cancer Prev 2010; 11: 905-911.
41. Xing L, Todd NW, Yu L, Fang HB, Jiang F,. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol 2010; 23: 1157-1164.
42. Saini S, Yamamura S, Majid S, et al. MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res 2011; 71: 6208-6219.
43. Kim K, Chadalapaka G, Lee S-O, et al. Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer. Oncogene 2011; 30: 1-11.
44. Li Y, Tan W, Neo TW, et al. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 2009; 100: 1234-1242.
45. Li Z, Yang C-S, Nakashima K, Rana TM,. Small RNA-mediated regulation of iPS cell generation. EMBO J 2011; 30: 823-834.
46. Cho WCS, Chow ASC, Au JSK,. MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol 201; 8: 125-131.
47. Liang L, Wong CM, Ying Q, et al. MicroRNA-125b suppresses human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology 2010; 52: 1731-1740.
48. Yekta S, Shih IH, Bartel DP,. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004; 304: 594-596.
49. Zhu S, Si ML, Wu H, Mo YY,. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007; 282: 14328-14336.
50. Gregersen LH, Jacobsen AB, Frankel LB, Wen J, Krogh A, Lund AH,. MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One 2010; 5: e8836.
51. Stinson S, Lackner MR, Adai AT, et al. miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer. Sci Signal 2011; 4: pt5.
52. Luthra R, Singh RR, Luthra MG, et al. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 2008; 27: 6667-6678.